Skip to main content

Table 5 Patient characteristics and implant specification

From: Horizontal augmentation techniques in the mandible: a systematic review

Author

Gender

Age (y)

Inclusion criteria

Exclusion criteria

Smoking

Systemic condition

Implant placement after augmentation (mths)

Types of implants

Mean follow-up (mths)

Amorfini et al. [101]

Median 59.5 (32–72)

Adult patients; bilateral atrophic edentulous areas in the posterior mandible

Systemic diseases affecting the bone metabolism

n/a

No systemic condition affecting bone metabolism

Simultaneous

SLActive; Straumann (Basel, Switzerland)

12

Barbu et al. [100]

13 female; 11 male

Mean 47.8 (24–71)

At least 10-mm residual height, but less than 4.3-mm bucco-lingual dimension

Smoking; uncontrolled systemic disease; active periodontal disease

Excluded

No uncontrolled systemic disease

4

TSV Zimmer Dental Inc (Carlsbad, California, USA)

19.8

Beitlitum et al. [117]

12 female; 3 male

Mean 53 (36–68)

Mandibular partial edentulism, horizontal bone deficiency that prevented implant placement

Presence of uncontrolled periodontal disease involving the residual dentition, an active endodontic condition involving the adjacent teeth

> 10cig/d excluded

No pregnancy or lactation, bone disease or medication interfering with bone metabolism, history of head and neck radiotherapy, metabolic disorders (eg, uncontrolled diabetes mellitus), immunodeficiency

5–7

6

Di Stefano et al. [104]

3 female; 2 male

Mean 45.5 (32–59)

Crestal width ≤ 4 mm, crestal height ≥ 10 mm, age > 30 years, controlled oral hygiene and absence of lesions

High degree of bruxism; excessive consumption of alcohol; localized radiation therapy of the oral cavity; inflammatory and autoimmune diseases of the oral cavity; and poor oral hygiene

> 10cig/d excluded

No antineoplastic chemotherapy; blood, liver, and kidney diseases; immunosuppression; corticosteroids and bisphosphonates therapy; pregnancy;

6

XiVE, Dentsply-Friadent, (Mannheim, Germany)

40.5

Nissan et al. [103]

18 female; 3 male

Mean 55.7

Patients with a mandibular alveolar ridge requiring a vertical and lateral augmentation of > 3 mm patients in good health

Contraindications to implant therapy

n/a

Healthy

6

Seven; MIS® (Savion, Israel) or Osseotite; Zimmer Biomet 3i (Warsaw, USA)

37 ± 17

Schwartz-Arad et al. [99]

50.3

Edentulous mandibular area with degree of atrophy preventing placement of implants of at least 6 mm in height without the risk of damaging anatomical structures

Poor oral hygiene noncompliance

18.2%

Exclusion of kidney/liver/connective tissue disease, immunodeficiency, chemotherapy, radiotherapy

5

Screw-Vent and Spline; Zimmer Biomet 3i, (Warsaw, USA) or NobelActive and Replace Select, Nobel Biocare (Goteborg, Sweden) or Implant Direct (Zurich, Switzerland)

39.9 ± 30.9

Silva et al. [105]

15 female; 5 male

Mean 51.8 (37–64)

Alveolar ridge width and/or height ≤ 6 mm; > 18 yrs. Good oral health, no active periodontal disease, or occlusal problems

Compromised oral or general health, pregnancy, alcohol abuse, radiotherapy, bisphosphonates

Excluded

Good general and mental health

6

TitamaxCM Cortical, Neodent, (Curitiba, Brazil)

31.8 ± 7

Urban et al. [102]

9 female; 3 male

51.4

Horizontal ridge of 4 mm or less, Cawood Howell Class IV, ability to maintain good oral hygiene

Smokers, patients with alcohol abuse, periodontal disease

Excluded

Systemically and periodontally healthy

6.9

Implants with an anodized TiUnite surface (Brånemark System, Nobel Biocare)

20.9 ± 9.5